Search results

• 2017

  Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes

  Ali, M. A., Liu, Y.-F., Arif, S., Tatovic, D., Shariff, H., Gibson, V. B., Yusuf, N., Baptista, R., Eichmann, M., Petrov, N., Heck, S., Yang, J. H. M., Tree, T. I. M., Pujol-Autonell, I., Yeo, L., Baumard, L. R., Stenson, R., Howell, A., Clark, A. & Boult, Z. & 19 others, Powrie, J., Adams, L., Wong, F. S., Luzio, S., Dunseath, G., Green, K., O'Keefe, A., Bayly, G., Thorogood, N., Andrews, R., Leech, N., Joseph, F., Nair, S., Seal, S., Cheung, H., Beam, C., Hills, R., Peakman, M. & Dayan, C. M., 9 Aug 2017, In: Science Translational Medicine. 9, 402, 10 p., eaaf7779.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Insulin Dependent Diabetes Mellitus 100%
  • Proinsulin 100%
  • Peptide 100%
  • C-Peptide 60%
  • Deterioration 40%
  154 Citations (Scopus)

  420 Downloads (Pure)